25.01.2015 Views

Prescribing in General Practice

Prescribing in General Practice

Prescribing in General Practice

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Adherence<br />

• Factors Affect<strong>in</strong>g Adherence (Patient / Doctor Factors)<br />

– Understand<strong>in</strong>g of the <strong>in</strong>structions<br />

• Age of patient<br />

• Educational level of patient<br />

• Complexity of regimen etc. (e.g. COCP, bisphosphonates)<br />

– Quality of doctor-patient <strong>in</strong>teraction<br />

– Family and social isolation<br />

– Beliefs, attitude and personality<br />

• Health belief model<br />

• Locus of control<br />

• Ego strength<br />

• Drug aversion<br />

Adherence<br />

• Factors Affect<strong>in</strong>g Adherence (Illness / Medication<br />

Factors)<br />

– Number of medications prescribed concurrently<br />

– Nature of illness<br />

• Asymptomatic<br />

• Psychiatric<br />

• Chronic<br />

– Use of medic<strong>in</strong>e for prevention rather than treatment<br />

– Number of troublesome side fx with the medic<strong>in</strong>e<br />

– Duration of therapy<br />

Adherence<br />

• Ways to Improve Adherence<br />

– Involve the patients and carers <strong>in</strong> the management<br />

– Choose the simplest regime possible<br />

• E.g. once weekly dos<strong>in</strong>g for bisphosphonates<br />

– Discuss the rationale fully<br />

– Simple written <strong>in</strong>structions<br />

– Review risk : benefit balance<br />

– Consider alternatives<br />

– Use expertise of local pharmacist<br />

– Monitor treatment<br />

• Review regularly re side fx etc. and adjust regime accord<strong>in</strong>gly<br />

Adherence<br />

• What should patients be told about their medication<br />

– The name of the medic<strong>in</strong>e<br />

– What it is for<br />

– How it works (or is thought to work)<br />

– Whether it is essential, important, or optional<br />

– How much to take, how to take, how often to take it and how<br />

long to take it for<br />

– What benefits to expect<br />

– What adverse effects might occur<br />

• Legal obligation to tell patients about common side fx and those that are<br />

potentially serious (even if rare) – <strong>in</strong>formed consent<br />

– What to do if no benefit, or less than expected benefit<br />

– What to do if adverse effects occur<br />

Special Circumstances<br />

• Special considerations are needed when prescrib<strong>in</strong>g for<br />

the follow<strong>in</strong>g patient groups:<br />

– The elderly<br />

– Children<br />

– Pregnant (or potentially pregnant) women<br />

– Breast-feed<strong>in</strong>g women<br />

– Term<strong>in</strong>al care<br />

– Co-exist<strong>in</strong>g medical conditions e.g. renal / liver failure<br />

– Particular drug categories e.g. warfar<strong>in</strong><br />

The Pharmaceutical Industry<br />

• Relationship between the Pharmaceutical Industry<br />

and doctors has come under <strong>in</strong>creas<strong>in</strong>g scrut<strong>in</strong>y<br />

– Irish Medical Council issued guidel<strong>in</strong>es <strong>in</strong> 2004<br />

• “Non-promotional educational grants represent the only<br />

acceptable mechanism of f<strong>in</strong>ancial support by the<br />

pharmaceutical and medical manufactur<strong>in</strong>g <strong>in</strong>dustries to<br />

<strong>in</strong>dividual doctors”<br />

– Pros:<br />

• The <strong>in</strong>dustry conducts almost all the research and<br />

development <strong>in</strong>to new drugs, that goes on <strong>in</strong> the world<br />

• Provide <strong>in</strong>formation and education to healthcare workers<br />

• Support the economy<br />

6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!